1.4M
Downloads
1076
Episodes
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes
Tuesday Dec 14, 2021
Tuesday Dec 14, 2021
A moderated panel of prominent female rheumatologists will discuss the challenges and successes in clinical practice and research that they encountered during the COVID-19 pandemic..
Monday Dec 13, 2021
Monday Dec 13, 2021
The ACR 2021 meeting has concluded. Dr. Jack Cush recants a few more great abstracts from this past weeks meeting.
Friday Dec 10, 2021
Friday Dec 10, 2021
Drs. Jack Cush and Martin Bergman gather to review the topic of treat-to-target (T2T) management in rheumatology. Both will debate the pro's and con's of the T2T strategy at the upcoming RWCS meeting on Feb. 17, 2022. You can register and learn more about the meeting at:
https://r-w-c-s.com/2022/
Friday Dec 03, 2021
Friday Dec 03, 2021
Dr. Jack Cush discusses the evolution and future of telemedicine in rheumatology with the telemedicine guru - Dr. Alvin Wells
Friday Nov 26, 2021
Friday Nov 26, 2021
Dr. Jack Cush interviews Professor Edward Keystone, MD (from the University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis.
Monday Nov 22, 2021
Monday Nov 22, 2021
Panelists: Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood.
Friday Nov 19, 2021
Friday Nov 12, 2021
Friday Nov 12, 2021
ALPN-303 - Dr. Pedro Castillo
Dr. Castillo reports on abstract #1429 presented at the ACR21 annual meeting.
Thursday Nov 11, 2021
Thursday Nov 11, 2021
JAK Safety -- The Lowdown on Infection: Drs. Kevin Winthrop and Jonathan Kay
Infections in ORAL Surveillance: Drs. Kevin Winthrop and Jonathan Kay
Infliximab Drug Monitoring in PsA, RA, AxSpA: Dr. Pedro Castillo
Lupus and Pregnancy: Dr. Sheila Reyes
Secukinumab Effect on CV Risks in PsA, axSpA: Dr. Sheila Reyes
Thursday Nov 11, 2021